1287944

Filipa Lynce, M.D. — FEI 3039284423

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 21, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Citations

IDCFRDescription
748021 CFR 312.50Ensuring compliance with plan and protocol